Group (n) | Mean (SD) age (years) | Sex M:F | Mean (SD) DD (years) | +ChEI | +L-dopa | Mean (SD) MMSE | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
DD, disease duration; +ChEI, number of patients taking a cholinesterase inhibitor at entry to the study: +L-dopa, number of patients taking L-dopa at entry to the study. *p<0.001, †p<0.0001. | |||||||||||
DLB (27) | 77.5 (6) | 15:12 | 2.7 (1.6) | 26 | 6 | 18.5 (4.6) | |||||
PDD (33) | 72.5 (5)* | 23:10 | 9 (5.8)† | 24 | 33 | 20.2 (5) | |||||
PD (31) | 77.1 (6) | 24:7 | 4.9 (4.6) | 0 | 19 | 26.0 (2.5)† |